Respiratory medicine

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS99
Academic Journal
Presents an abstract of the research manuscript `Improved clearability of cystic fibrosis sputum with dextran treatment in vitro,' by W. Feng et al.


Related Articles

  • New drug for cystic fibrosis shows promise.  // Modern Medicine;Feb95, Vol. 63 Issue 2, p56 

    Presents an abstract of the article `Effect of Aerosolized Recombitant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis by H.J. Fuchs, D.S. Borowitz, et al from the periodical `The New England Journal of Medicine,' dated September 8,...

  • Cystic fibrosis therapy, detection improving.  // Newsweek;5/12/1986, Vol. 107 Issue 19, p69 

    Cystic fibrosis is one of the cruelest and most common genetically transmitted illnesses in the US, with more than 30,000 sufferers at any given time. Now, however, improvements in treatments are extending the lives of cystic fibrosis patients, and recent developments in biotechnology are...

  • Liberated lungs.  // New Scientist;8/21/93, Vol. 139 Issue 1887, p11 

    Reports on the recommendation for the approval of the pulmozyme drug by the Pulmonary-Allergy Drugs Advisory Committee to the Food and Drug Administration. Treatment for cystic fibrosis; Improvement of lung function; Alleviation of lung symptoms; Side effects.

  • Efficacy of Aerosolized Tobramycin in Patients with Cystic Fibrosis. Ramsey, Bonnie W.; Dorkin, Henry L.; Eisenberg, Jay D.; Gibson, Ronald L.; Harwood, Ivan R.; Kravitz, Richard M.; Schidlow, Daniel V.; Wilmott, Robert W.; Astley, Susan J.; McBurnie, Mary Ann; Wentz, Kim; Smith, Arnold L. // New England Journal of Medicine;6/17/93, Vol. 328 Issue 24, p1740 

    Background: Direct aerosol delivery of aminoglycosides such as tobramycin to the lower airways of patients with cystic fibrosis may control infection with Pseudomonas aeruginosa and improve pulmonary function, with low systemic toxicity. We conducted a randomized crossover study to evaluate the...

  • Closing in on cystic-fibrosis. Cowley, Geoffrey // Newsweek;5/3/1993, Vol. 121 Issue 18, p56 

    Reports that on April 17, a 23-year-old man with advanced cystic fibrosis became the first patient to receive a treatment aimed at correcting cystic-fibrosis, the fatal respiratory disorder, at its source. In an audacious experiment, doctors at the National Heart, Lung and Blood Institute...

  • Drug disposition in cystic fibrosis. Rey, E.; Tréluyer, J-M.; Pons, G.; Tréluyer, J M // Clinical Pharmacokinetics;1998, Vol. 35 Issue 4, p313 

    There are many pathological changes in patients with cystic fibrosis (CF) which can lead to alterations in drug disposition. Although, in patients with CF, the extent of drug absorption varies widely and the rate of absorption is slower, bioavailability is not altered. Plasma protein binding for...

  • Family of girl with cystic fibrosis to walk m fundraiser. Collier, Jessica // Adirondack Daily Enterprise;5/22/2010, Vol. 117 Issue 121, pA1 

    The article reports on the effort of a local family in Tupper Lake, New York, who has a daughter with cystic fibrosis, to join a walk to raise funds to find a cure for the disease.

  • Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Hyde, Stephen C.; Gill, Deborah R. // Nature;3/18/1993, Vol. 362 Issue 6417, p250 

    Reports the use of liposomes to deliver a cystic fibrosis conductance regulator (CFTR) expression plasmid to epithelia of the airway and to alveoli deep in the lung, leading to the correction of the ion conductance defects found in the trachea of transgenic (cf/cf) mice. Expression of...

  • Vital research caught in patent crossfire. Coghlan, Andy // New Scientist;1/23/93, Vol. 137 Issue 1857, p4 

    Reports that some scientists may be caught in a patent crossfire over research they are conducting into cystic fibrosis. Institutions that have applied for a patent on the defective gene that causes cystic fibrosis; Lack of a decision concerning the patent by the United States patent office;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics